MedPath

A Study to Investigate the Possible Causes of Secondary Effects During Use of Peripheral Midline Type Catheter in Patients Hospitalized in Different Care Settings

Completed
Conditions
Upper Extremity Deep Vein Thrombosis, Secondary
Registration Number
NCT04391205
Lead Sponsor
A.O.U. Città della Salute e della Scienza
Brief Summary

Although the use of peripheral venous catheters (CVP) with brachial insertion with echo-guide (Midline) has increased significantly over the last 5-10 years, there are no sensitive data concerning complications in the literature during their use, particularly as regards incidence of thrombotic complication.The prospective observational study will enroll all the patients admitted to Home Health Hospitalization service, Geriatric Department and Intermediate Care service, to whom a Midline-type CVP will be placed for infusional therapy and who will give their consent to participate.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
211
Inclusion Criteria
  • Subjects admitted to wards adhering to the study (Home Health Hospitalization service, Geriatric Department and Intermediate Care service)
  • Subjects submitted to Midline type venous catheter insertion
Exclusion Criteria
  • History of deep venous thrombosis or pulmonary embolism
  • Be hospitalized for less than a week

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Number of participants with Peripheral deep venous thrombosis (DVP) suspected with Compression ultrasound (CUS) and confirmed by echodopplerOnce a week from the implant day until CVP removal or patient discharge, whichever came first, assessed up to 40 days

Deep vein thrombosis is investigated with Compression ultrasound (CUS) technique, scheduled once a week from the implant day or performed at the time of occurrence of device malfunctions or at the onset of symptoms resulting from thrombotic complications; echodoppler tecnique is used to confirm diagnosis of thrombosis.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Marinello Renata

🇮🇹

Turin, Italy

© Copyright 2025. All Rights Reserved by MedPath